Mitchell P. Kopin 13D and 13G filings for Phio Pharmaceuticals Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-17 4:44 pm Purchase |
2025-01-13 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 530,171 9.990% |
439,184 (+482.69%) |
Filing |
| 2024-12-27 5:05 pm Purchase |
2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 90,987 4.990% |
45,782 (+101.28%) |
Filing |
| 2024-11-13 11:20 am Purchase |
2024-09-30 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 45,205 4.990% |
45,205 (New Position) |
Filing |